Further isolation of Mycobacterium abscessus subsp. abscessus and subsp. bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agents

International Journal of Antimicrobial Agents

Volumn 42, Issue 3, 2013, Pages 226-231

  Yoshida, Shiomi ^a   Tsuyuguchi, Kazunari ^a   Suzuki, Katsuhiro ^a   Tomita, Motohisa ^a   Okada, Masaji ^a   Hayashi, Seiji ^a   Iwamoto, Tomotada ^b   Saito, Hajime ^c  

^a NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^b KOBE INSTITUTE OF HEALTH   (Japan)

^c Hiroshima Environment and Health Association   (Japan)

Author keywords

Clarithromycin; Genetic distribution; In vitro susceptibility; Mycobacterium abscessus subsp. Abscessus; Mycobacterium abscessus subsp. Bolletii

Indexed keywords

CLARITHROMYCIN; INTERNAL TRANSCRIBED SPACER; LINEZOLID; RNA POLYMERASE BETA SUBUNIT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; ERM(41) GENE; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; HSP65 GENE; JAPAN; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM BOLLETII; NONHUMAN; PRIORITY JOURNAL; RPOB GENE; RRL GENE; SEQUENCE ANALYSIS; SPECIES DIFFERENCE;

CLARITHROMYCIN; GENETIC DISTRIBUTION; IN VITRO SUSCEPTIBILITY; MYCOBACTERIUM ABSCESSUS SUBSP. ABSCESSUS; MYCOBACTERIUM ABSCESSUS SUBSP. BOLLETII;

ACETAMIDES; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; CHAPERONIN 60; CLARITHROMYCIN; DNA, INTERGENIC; DRUG RESISTANCE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; JAPAN; MALE; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; OXAZOLIDINONES; RNA, RIBOSOMAL, 23S; SEQUENCE ANALYSIS, DNA;

EID: 84883466329     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.04.029     Document Type: Article

References (15)

1. M. Tsukamura, H. Shimoide, N. Kita, K. Kawakami, T. Ito, and N. Nakajima Epidemiologic studies of lung disease due to mycobacteria other than Mycobacterium tuberculosis in Japan Rev Infect Dis 3 1981 997 1007
2. T. Adékambi, and M. Drancourt Mycobacterium bolletii respiratory infections Emerg Infect Dis 15 2009 302 305
3. S.C. Leao, E. Tortoli, J.P. Euzéby, and M.J. Garcia Proposal that Mycobacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description of Mycobacterium abscessus Int J Syst Evol Microbiol 61 2011 2311 2313
4. Harada T, Akiyama Y, Kurashima A, Nagai H, Tsuyuguchi K, Fujii T, et al. Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases. J Clin Microbiol 2012;50:3556-61. Errata in: J Clin Microbiol 2013;51:736; J Clin Microbiol 2013;51:1061.
5. H-Y. Kim, Y. Kook, Y-J. Yun, C.G. Park, N.Y. Lee, and T.S. Shim Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates J Clin Microbiol 46 2008 3384 3390
6. K. Nakanaga, Y. Hoshino, Y. Era, K. Matsumoto, Y. Kanazawa, and A. Tomita Multiple cases of cutaneous Mycobacterium massiliense infection in a 'hot spa' in Japan J Clin Microbiol 49 2011 613 617
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Document M100-S21. Wayne, PA: CLSI; 2011.
8. Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard. 2nd ed. Document M24-A2. Wayne, PA: CLSI; 2011.
9. S. Bastian, N. Veziris, A.L. Roux, F. Brossier, J.L. Gaillard, and V. Jarlier Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing Antimicrob Agents Chemother 55 2011 775 781
10. H-Y. Kim, B.J. Kim, Y. Kook, Y-J. Yun, J.H. Shin, and B-J. Kim Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns Microbiol Immunol 54 2010 347 353
11. J. van Ingen, R. de Zwaan, R.P. Dekhuijzen, M.J. Boeree, and D. van Soolingen Clinical relevance of Mycobacterium chelonae-abscessus group isolation in 95 patients J Infect 59 2009 324 331
12. G.L. Woods, J.S. Bergmann, F.G. Witebsky, G.A. Fahle, B. Boulet, and M. Plaunt Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum J Clin Microbiol 38 2000 656 661
13. S. Chihara, G. Smith, and C.A. Petti Carbapenem susceptibility patterns for clinical isolates of Mycobacterium abscessus determined by the Etest method J Clin Microbiol 48 2010 579 580
14. S-C. Yang, P-R. Hsueh, H-C. Lai, L-J. Teng, L-M. Huang, and J-M. Chen High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan Antimicrob Agents Chemother 47 2003 1958 1962
15. W-J. Koh, K. Jeon, N.Y. Lee, B-J. Kim, Y-H. Kook, and S-H. Lee Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus Am J Respir Crit Care Med 183 2011 405 410